Evolus (EOLS) Interest Coverage Ratio Growth (3y) (2020 - 2026)
Evolus (EOLS) Interest Coverage Ratio Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.14% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.23% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -28.01% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -32.31% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 26.99% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 41.72% |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | 10.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.03% |
| Dec 31, 2025 | 28.29% |
| Sep 30, 2025 | 12.66% |
| Jun 30, 2025 | 14.64% |
| Mar 31, 2025 | -48.69% |
| Dec 31, 2024 | -26.88% |
| Sep 30, 2024 | -450.76% |
| Jun 30, 2024 | -5.60% |
| Mar 31, 2024 | -69.21% |
| Dec 31, 2023 | 69.19% |
| Sep 30, 2023 | 1.65% |
| Jun 30, 2023 | 26.56% |
| Mar 31, 2023 | 20.34% |
| Dec 31, 2022 | 13.35% |
| Sep 30, 2022 | -35.49% |
| Jun 30, 2022 | 21.56% |
| Mar 31, 2022 | -21.91% |
| Sep 30, 2021 | 95.00% |
| Jun 30, 2021 | 81.43% |
| Mar 31, 2021 | 26.16% |